Actively Recruiting
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.
Led by IRCCS San Raffaele · Updated on 2024-08-22
100
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
Sponsors
I
IRCCS San Raffaele
Lead Sponsor
F
Fondazione Policlinico Universitario Campus Bio-Medico
Collaborating Sponsor
AI-Summary
What this Trial Is About
Prospective observational clinical, molecular, translational study aimed at identifying the main determinants and predictive factors of fragility fracture risck in acromegaly patients
CONDITIONS
Official Title
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of acromegaly
- Availability to carry out outpatient checks
- Ability to provide informed consent
You will not qualify if you...
- Pregnancy
- Use of glucocorticoids (except those in use for replacement therapy)
- Alcohol abuse
- Exacerbation of chronic disease
- Serious comorbidities such as renal or hepatic failure, heart attack, stroke
- Terminal illness or prolonged immobilization (more than 1 week)
- Clinically evident fracture within the previous six months
- Any other cause of secondary osteoporosis within the last five years
- Prolonged treatment with drugs affecting bone metabolism during the past 12 months, including antiresorptive or anabolic compounds for osteoporosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Andrea Giustina
Milan, Italy, 20132
Actively Recruiting
Research Team
S
Stefano Frara, MD
CONTACT
G
Gabriela Felipe, Nurse
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here